Latest Registration & Listings Compliance Articles
European Regulatory Agencies and Market Access: Understanding HMA, EDQM, Swissmedic, and MHRA 

Understanding the various European Pharmaceutical Regulatory Authorities and how they affect market access, including HMA, EDQM, Swissmedic, and MHRA.

Read More
How Pharmaceutical Companies Can Simplify Active Substance Master File Procedures

Managing EMA ASMF submissions can be complex. Learn how pharmaceutical companies simplify Active Substance Master File procedures & regulatory management.

Read More
Why FDA Is Detaining More API & Bulk Ingredient Shipments — and How to Avoid It

Avoid FDA API and bulk ingredient shipment detentions. Learn common registration, listing, and NDC errors—and how Registrar Corp helps keep imports compliant and moving.

Read More
FDA Scrutiny in 2026: Top 5 Regulatory Risks for Drug Manufacturers

FDA scrutiny is intensifying. Learn the 5 critical regulatory risks facing drug manufacturers in 2026 and the strategic shift you must make to protect market access.

Read More
FDA New Drug Applications (NDA): A Complete Guide to 505B1 Approval

Learn how to navigate the FDA’s 505B1 NDA process—from data requirements to approval timelines, labeling, and compliance. Avoid delays with expert guidance.

Read More
505B2 NDA Explained: A Strategic Pathway to FDA Drug Approval Using Existing Data

Learn how to leverage the 505B2 NDA pathway for faster FDA approval. Use existing data, reduce costs, and gain exclusivity for differentiated drug products.

Read More


To top